Although IL-1α is mainly retained intracellularly, a naturally occurring human IL-1α neutralizing antibody MABp1 (XBiotech Inc., Austin, TX, USA) and an antibody targeting IL-1α (Bermekimab) have shown promising results with several types of cancers [14,84]. This evidence concerns the gene IL1A and cancer.